Background Opioid-related deaths have risen dramatically in rural communities. Prior
studies highlight few medication treatment providers for opioid use disorder in rural …

In the midst of an opioid epidemic, mortality related to opioid overdose continues to rise in
the US. Medications to treat opioid use disorder, including methadone and buprenorphine …

Objectives. We estimated national and state trends in opioid agonist medication-assisted
treatment (OA-MAT) need and capacity to identify gaps and inform policy decisions …

All-cause mortality rates in rural areas have exceeded those in urban areas of the US since
the 1980s, and the gap continues to widen. Yet no definitive causes of this difference are …

Description: In May 2022, leadership within the US Department of Veterans Affairs (VA) and
US Department of Defense (DoD) approved a joint clinical practice guideline for the use of …

Background: Opioid use disorders (OUDs) are reaching epidemic proportions in the United
States, and many geographic areas struggle with a persistent shortage in availability of …

Background Maintenance treatments with medications for opioid use disorder (MOUD) are
highly effective at reducing overdose risk while patients remain in care. However, few …

People in the US criminal justice system experience high rates of opioid use disorder,
overdose, and other adverse outcomes. Expanding treatment is a key strategy for …

Background and Objectives The opioid epidemic in the United States has resulted in a
public health emergency. Medication‐assisted treatment (MAT) with methadone and …

Abstract Background Within the United States, there is a shortage of opioid treatment
programs (OTPs), facilities which dispense methadone for opioid use disorder. It is unknown …